Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Mitigation of Arthrofibrosis After Total Knee Arthroplasty
NCT06108063Phase 2Recruiting
- Sponsor
- Steadman Philippon Research Institute
- Start
- Mar 2024
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Arthrofibrosis comparing Losartan with Placebo (2 arms). Primary endpoints: Quantitative Ultrasound Measurement of Capsular Thickness at Lateral Retinaculum and Knee Range of Motion. Started Mar 2024; status: recruiting.
02
Drugs
losartan
03
Conditions
Arthrofibrosis
Beyond the preview
Go deeper on NCT06108063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06108063.